The Boston Beer Company Statement on Company Sale Speculation
Boston, May 31, 2024 (GLOBE NEWSWIRE) — The Boston Beer Company, Inc. (NYSE: SAM) is aware of today’s Wall Street…
Brand Post
Johnson & Johnson submits application to the European Medicines Agency seeking approval of subcutaneous formulation of RYBREVANT®▼ (amivantamab) for the treatment of patients with EGFR-mutated non-small cell lung cancer
Submission is supported by data from the Phase 3 PALOMA-3 study featured at the American Society of Clinical Oncology (ASCO)…
Book Aleutian Airways Flights on AlaskaAir.com and Earn Alaska Airlines Miles
ANCHORAGE, Alaska, May 31, 2024 /PRNewswire/ -- Aleutian Airways, operated by Sterling Airways, is excited to announce a new way…
Textile Pretreatment Chemicals Market size is set to grow by USD 1.76 billion from 2024-2028, Growing textile industry in developing economies to boost the market growth, Technavio
NEW YORK, May 31, 2024 /PRNewswire/ -- The global textile pretreatment chemicals market size is estimated to grow by USD…
Textile Industry Waste Management Market size is set to grow by USD 2.32 billion from 2024-2028, Increasing awareness about sustainability and environmental protection to boost the market growth, Technavio
NEW YORK, May 31, 2024 /PRNewswire/ -- The global textile industry waste management market size is estimated to grow by USD 2.32…
RYBREVANT®▼ (amivantamab) plus lazertinib shows longer progression-free survival versus osimertinib in the first-line treatment of patients with high-risk EGFR-mutated non-small cell lung cancer
Investigational chemotherapy-free regimen of amivantamab plus lazertinib addresses a significant unmet need as most patients with EGFR-mutated NSCLC have high-risk…
Arizona Woman Killed in Pedestrian vs. Truck Accident on I-10 Near Boerne
BOERNE, Texas, May 31, 2024 /PRNewswire/ -- Grossman Law Offices, with its principal office in Dallas, TX, reports on an…
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution
HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical…
Huntington Bancshares to Present at the 2024 Morgan Stanley US Financials, Payments and CRE Conference
COLUMBUS, Ohio, May 31, 2024 /PRNewswire/ -- Huntington Bancshares Incorporated (Nasdaq: HBAN) will participate in the 2024 Morgan Stanley US…
AZZ Inc. to Participate in the Stifel Cross Sector Insight Conference and 14th Annual East Coast IDEAS Conference in June 2024
FORT WORTH, Texas, May 31, 2024 /PRNewswire/ -- AZZ Inc. (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and…
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma…
Metasphere Labs Focuses its Carbon Aware Routing Protocol
VANCOUVER, British Columbia, May 31, 2024 (GLOBE NEWSWIRE) — Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., “Metasphere Labs” or…
↑